Clinical Trials Logo

Clinical Trial Summary

The aim of our study was: a) to evaluate the usefulness of the MR model for renal pedicle exposure and identification of the tumor's exact location during LPN, and b) to evaluate the subjective utility of the MR model as an intraoperative reference tool. Investigators prospectively enrolled 47 patients with LPN between June 2020 and February 2021. Patients were randomly assigned into two groups: the control group (24 patients), who underwent operation with an intraoperative ultrasound (US) control and the experimental group (23 patients), who underwent operation with the aid of the MR model. Randomization was performed using a computerized randomization program and sealed envelopes. Patients were included in the study if they were 18 years of age or older, were able to sign informed consent, and had T1a renal tumors amenable to LPN. Patients were excluded if they were unwilling to participate or did not meet the inclusion criteria. For each patient, investigators prospectively collected demographic data including age, body mass index, clinical tumor size, side, location, and complexity score according to the PADUA scoring system; perioperative data (including time for renal pedicle exposure and time for renal tumor detection and duration of ischemia); pathological data; data on postoperative functional outcome and complications, classified according to the Clavien-Dindo system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05015179
Study type Interventional
Source St. Petersburg State Pavlov Medical University
Contact
Status Completed
Phase N/A
Start date June 1, 2020
Completion date March 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT01950923 - Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer Phase 1
Withdrawn NCT01688414 - Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer N/A
Recruiting NCT05387863 - Decision Aid (DA) for Renal Patients N/A
Active, not recruiting NCT03819569 - GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses N/A
Recruiting NCT06056505 - Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy N/A
Recruiting NCT01967407 - IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. Phase 1/Phase 2
Terminated NCT00960063 - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Phase 1
Recruiting NCT05890781 - Engineering Immune Organoids to Study Pediatric Cancer N/A
Completed NCT00019630 - Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Phase 1
Completed NCT01908166 - Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions N/A
Recruiting NCT05728957 - Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors